Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04829877
Other study ID # N201807030
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date April 19, 2022
Est. completion date January 2024

Study information

Verified date April 2023
Source Taipei Medical University
Contact Shu-Yu Kuo, Phd
Phone +886-2-2736-1661
Email sykuo@tmu.edu.tw
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Background: Infertility is a serious reproductive health issue and affects 48.5 million couples worldwide. Women undergoing fertility treatment often experienced psychological distress but also social stigma that is close linked to later pregnancy outcome. Despite the advancement in assisted reproductive technology, effective interventions for reducing stress, anxiety, and depressive symptoms for infertility women remain lacking. Objectives: The objective of this proposal is to evaluate the efficacy of web-based mind-body intervention combining HRV biofeedback on the infertility women's anxiety symptoms, levels of depression, HRV function, mindful awareness, infertility self-efficacy, and pregnancy rates. Methods: We plan to conduct a randomized controlled trial on the web-based mind-body intervention combining heart rate variability biofeedback. Eligible women will be recruited and randomized into three groups. Intention-to-treat analysis and mixed regression modeling will be used to estimate the effectiveness of the interventions. Anticipatory results: Effective strategies will be determined for infertility women.


Description:

A designed data entry system for the current study will be developed to ensure an error-proof process. It is important to inspect data for outliers, wild code, and consistency to maintain the data quality in the pre-analysis data phase. We will assess the amount and pattern of missing values by using descriptive statistics, such as frequency and percentage. The pattern of missing data will be identified and decide whether the missing completely at random or not. The appropriate corresponding method will be adopted for the subsequent statistical analyses. For example, the mean imputation is considered when the percentage of items missing at a given questionnaire is less than 10 %. The mean imputation will be used to replaces a missing value with the item mean when applicable. The comparison between complete case analysis and imputation data will be performed to assess the reliability and validity of the results.


Recruitment information / eligibility

Status Recruiting
Enrollment 750
Est. completion date January 2024
Est. primary completion date January 2024
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 20 Years to 60 Years
Eligibility Inclusion Criteria: - 20-year-old and above - Seeking infertility care - Contemplating pregnancy - Intended to start their ART cycle - Able to speak Taiwanese or Mandarin Exclusion Criteria: - Diagnosis of cardiovascular disease, depressive disorder, anxiety disorder, cardiac arrhythmia - Already had started their ART treatment - Taking medications that might affect ANS activity

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Web-based mind-body intervention with HRVB
The web-based mind-body intervention with HRVB contains the following components: 1) Breathing training with HRV biofeedback; 2) 5 different topics will be included ; 3) Home exercise of slow breathing and mindfulness exercise.
Web-based mind-body intervention
The web-based mind-body intervention will receive 5 different topics courses.

Locations

Country Name City State
Taiwan Infertility clinic Taipei

Sponsors (1)

Lead Sponsor Collaborator
Taipei Medical University

Country where clinical trial is conducted

Taiwan, 

Outcome

Type Measure Description Time frame Safety issue
Primary Anxiety Anxiety symptoms will be assessed using the Taiwanese version of the State Anxiety Inventory (SAI). Baseline
Primary Anxiety Anxiety symptoms will be assessed using the Taiwanese version of the State Anxiety Inventory (SAI). 1 week post-intervention
Primary Anxiety Anxiety symptoms will be assessed using the Taiwanese version of the State Anxiety Inventory (SAI). 1 month post-intervention
Primary Anxiety Anxiety symptoms will be assessed using the Taiwanese version of the State Anxiety Inventory (SAI). 2 month post-intervention
Primary Anxiety Anxiety symptoms will be assessed using the Taiwanese version of the State Anxiety Inventory (SAI). 3 month post-intervention
Secondary Depressive symptoms The Taiwanese version of the Beck Depression Inventory (BDI) will be used to assess depressive symptoms among infertility women. Baseline, post-intervention 1 week, month 1 , 2 and 3
Secondary HRV function The HRV signal will be measured using standard equipment. Baseline, post-intervention 1 week, month 1 , 2 and 3
Secondary Mindful awareness The Taiwanese version of the Five Facet Mindfulness Questionnaire (FFMQ) will be adopted to assess levels of mindfulness. Baseline, post-intervention 1 week, month 1 , 2 and 3
Secondary Infertility self-efficacy The infertility Self-Efficacy Scale (ISE) will be used for studied women. Baseline, post-intervention 1 week, month 1 , 2 and 3
Secondary Pregnancy rates Clinical pregnancy will be defined as a positive blood, urinary pregnancy test. 15 days after embryo transfer or ultrasound
See also
  Status Clinical Trial Phase
Completed NCT03607409 - Role of Inhibin A as Biomarker for Ovarian Response for IVF Treatment
Recruiting NCT02312076 - GnRHa for Luteal Phase Support in Long GnRHa Protocol Cycles Phase 4
Terminated NCT02161861 - Improvement of IVF Fertilization Rates, by the Cyclic Tripeptide FEE - Prospective Randomized Study N/A
Completed NCT03287479 - Comparison of a Semi-automated Closed Vitrification System (Gavi®) With a Manual Open Vitrification Sytem (Cryotop®) N/A
Terminated NCT03522350 - Randomized Trial Comparing EmbryoScope With EmbryoScope+. N/A
Completed NCT04496284 - Embryo Transfer Outcomes After Vitrification With Slush Nitrogen Compared to Liquid Nitrogen N/A
Completed NCT03623659 - pArtiaL zonA pelluciDa Removal by assisteD hatchINg of Blastocysts N/A
Completed NCT03895099 - New Ovarian Stimulation With Random Start, Use of Progestin Protocol for Oocyte Donors Phase 3
Active, not recruiting NCT04142112 - Randomized, Standard-Controlled, Study to Evaluate the Ohana IVF Sperm Preparation Kit, SPeRtility IVF Next Generation N/A
Completed NCT03152643 - Cumulative Live Birth Rates After Cleavage-stage Versus Blastocyst-stage Embryo Transfer N/A
Recruiting NCT03683771 - Assessment of Endometrial Pattern and Sub-endometrial Vascularity in ICSI Outcome
Recruiting NCT03161119 - Comparing Two Different Embryo Transfer Catheters N/A
Completed NCT04108039 - Micronized Progesterone vs Gonadotropin-releasing Hormone (GnRH) Antagonist in Freeze-all IVF Cycles. N/A
Completed NCT03677492 - Supplementing Intracytoplasmic Sperm Injection Handling Medium With Cytochalasin D ( ICSI-CD) N/A
Completed NCT03678558 - Oocyte Vitrification Aided With Cytochalasin B N/A
Completed NCT03678571 - Oocyte Vitrification Aided With Latrunculin A N/A
Completed NCT03678584 - Supplementing Intracytoplasmic Sperm Injection Handling Medium With Chaetoglobosin A ( ICSI-CA) N/A
Completed NCT03678818 - Supplementing Intracytoplasmic Sperm Injection Handling Medium With Latrunculin A (ICSI-LA) N/A
Completed NCT03678610 - Handling Medium for ICSI With Ionomycin and Latrunculin A N/A
Completed NCT03678597 - Supplementing Intracytoplasmic Sperm Injection Handling Medium With Latrunculin B ( ICSI-LB) N/A